Typhoid outbreak with a novel S. Typhi clone harbors resistance to three first-line antibiotics - chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole
There is currently a major outbreak of drug-resistant typhoid in Pakistan, and an isolated case in the UK following air travel, a research team at Public Health England and Aga Khan University, Pakistan, reports. This study shows the typhoid strain causing the outbreak acquired an additional piece of DNA to become resistant to multiple antibiotics, including a third-generation antibiotic.
‘This study reports a major outbreak of typhoid that is resistant to the most popular antibiotics. It highlights three major problems - the need for new antibiotics, the ability of the typhoid causing bacteria to become drug-resistant, and the possibility of a drug-resistant typhoid pandemic.’
The results suggest that treatment options are running out for typhoid, and there is an urgent need for preventative strategies including vaccines.Currently, an outbreak of drug-resistant typhoid is spreading through Pakistan and an emergency vaccination campaign is underway.
The outbreak began in November 2016, and was immediately recognized and reported to provincial public health authorities in Pakistan, where investigation into possible sources and control measures including use of a vaccine are ongoing. Public health alerts helped physicians recognize cases of typhoid that were resistant to ceftriaxone, an antibiotic reserved to treat multidrug-resistant infections. This strain was resistant to five antibiotics in total, a higher level of resistance than previously seen. The doctors treated the infections with the few remaining antibiotic options.
In the spring of 2017, collaborators Professor Rumina Hasan and Dr Sadia Shakoor from the Aga Khan University in Pakistan contacted the Wellcome Sanger Institute to genetically analyse the outbreak. Sanger Institute scientists performed whole genome sequencing of typhoid samples from Pakistan to investigate the genetic cause behind its high level of antibiotic resistance.
The team discovered that the typhoid outbreak was caused by strain H58, a strain known to be associated with multidrug-resistance. When researchers looked further, they found this strain of H58 had gained an extra strand of bacterial DNA - a plasmid - that encoded for additional antibiotic resistance genes. The typhoid possibly picked up the plasmid from E. coli.
Advertisement
Professor Gordon Dougan, a senior author from the Wellcome Sanger Institute and University of Cambridge Department of Medicine, said: "We have used genetic sequencing to uncover how this particular strain of typhoid became resistant to several key antibiotics. Sporadic cases of typhoid with these levels of antimicrobial resistance have been seen before, but this is the first time we've seen an ongoing outbreak - which is concerning."
Advertisement
Dr Charlie Weller, Wellcome's Head of Vaccines, said: "The treatment options for typhoid are running out. It's time we focus on prevention, in addition to treatment. Vaccines offer another way to tackle drug-resistant infections and we have a unique opportunity to address typhoid with a new Typhoid Conjugate Vaccine that has been recently pre-qualified by the World Health Organization."
Typhoid fever is a bacterial infection caused by the bacterium Salmonella enterica serovar Typhi. It is highly contagious, and spreads through a human population in areas with poor water sanitation when contaminated food or water is consumed. Symptoms include fever, stomach pain, headache and constipation or diarrhoea, and if left untreated it can become fatal.
The complete report is published in the journal mBio.
Source-Eurekalert